Umbria ERDF Project

TES announces the successful awarding of a European Regional Development Fund, Umbria project, “Integrated platform for innovative drug research and development for oncological and metabolic diseases “, partnered with leading local and international companies, Dompè Farmaceutici SpA, Sterling SpA, and Molecular Horizion Srl. The project aims to investigate novel targets for oncology and metabolic diseases and create an integrated drug discovery platform.

We use cookie to ensure that we give you best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies on the TES Pharma website. Read more about our Cookie Policy and Privacy PolicyOK